Supplementary Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

Autor: Luis Álvarez-Vallina, Pablo Menéndez, Manel Juan, Pedro Roda-Navarro, María L. Toribio, Laura Sanz, Sonia Guedan, Estela Paz-Artal, Pablo Morales, Maria Neves, Carmen Domínguez-Alonso, Anaïs Jiménez-Reinoso, Laura Rubio-Pérez, Ainhoa Erce-Llamazares, Simon Lykkemark, Marta Compte, Seandean L. Harwood, Sergi Betriu, Berta Marzal, Maria Castellà, Alejandro Segura-Tudela, Laura Díez-Alonso, Antonio Tapia-Galisteo, Samanta Romina Zanetti, Francisco Gutierrez-Agüera, Óscar Aguilar-Sopeña, Patricia Fuentes, Lidia Argemí-Muntadas, Clara Bueno, Ángel Ramírez-Fernández, Belén Blanco

Supplementary Data from Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181012a204af0f13777e162dffd1b6b5
https://doi.org/10.1158/2326-6066.22544789

Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

Autor: Belén Blanco, Ángel Ramírez-Fernández, Clara Bueno, Lidia Argemí-Muntadas, Patricia Fuentes, Óscar Aguilar-Sopeña, Francisco Gutierrez-Agüera, Samanta Romina Zanetti, Antonio Tapia-Galisteo, Laura Díez-Alonso, Alejandro Segura-Tudela, Maria Castellà, Berta Marzal, Sergi Betriu, Seandean L. Harwood, Marta Compte, Simon Lykkemark, Ainhoa Erce-Llamazares, Laura Rubio-Pérez, Anaïs Jiménez-Reinoso, Carmen Domínguez-Alonso, Maria Neves, Pablo Morales, Estela Paz-Artal, Sonia Guedan, Laura Sanz, María L. Toribio, Pedro Roda-Navarro, Manel Juan, Pablo Menéndez, Luis Álvarez-Vallina

Publikováno v: Blanco, B, Ramírez-Fernández, Á, Bueno, C, Argemí-Muntadas, L, Fuentes, P, Aguilar-Sopeña, Ó, Gutierrez-Agüera, F, Zanetti, S R, Tapia-Galisteo, A, Díez-Alonso, L, Segura-Tudela, A, Castellá, M, Marzal, B, Betriu, S, Harwood, S L, Compte, M, Lykkemark, S, Erce-Llamazares, A, Rubio-Pérez, L, Jiménez-Reinoso, A, Domínguez-Alonso, C, Neves, M, Morales, P, Paz-Artal, E, Guedan, S, Sanz, L, Toribio, M L, Roda-Navarro, P, Juan, M, Menéndez, P & Álvarez-Vallina, L 2022, ' Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers ', Cancer Immunology Research, vol. 10, no. 4, pp. 498-511 . https://doi.org/10.1158/2326-6066.CIR-21-0853
Cancer Immunol Res
CANCER IMMUNOL RES
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

Chimeric antigen receptor (CAR)–modified T cells have revolutionized the treatment of CD19-positive hematologic malignancies. Although anti-CD19 CAR-engineered autologous T cells can induce remission in patients with B-cell acute lymphoblastic leuk

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1733fee7c6ebbbcbbf623503ab2b511
https://pure.au.dk/portal/da/publications/overcoming-carmediated-cd19-downmodulation-and-leukemia-relapse-with-t-lymphocytes-secreting-anticd19-tcell-engagers(eb3f68d9-feb9-4a0f-8ba1-4fb9dc0f786a).html